Remoroza, Trixie F.
HRN: 21-47-73 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/22/2022
AMPICILLIN 500MG (VIAL)
06/22/2022
06/29/2022
IV
185mg
Q6
Pcap C
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Non-compliant To Guidelines